Publications by authors named "Bahareh Bayati"

α-Glucosidase inhibitors are important in the treatment of type 2 diabetes by regulating blood glucose levels and reducing carbohydrate absorption. The present study focuses on identifying new inhibitors bearing imidazo[1,2-c]quinazoline backbone through multi-step synthesis. The inhibitory potencies of the novel derivatives were tested against Saccharomyces cerevisiae α-glucosidase, revealing IC values ranging from 50.

View Article and Find Full Text PDF
Article Synopsis
  • - Diabetes is a major health issue, with 382 million people affected globally in 2013 and projections to rise to 592 million by 2035, primarily involving type 2 diabetes, characterized by insulin issues.
  • - Researchers synthesized benzimidazole-based derivatives to evaluate their potential as antidiabetic agents, conducting reactions and various spectroscopy methods to confirm the structures of these compounds.
  • - Out of 32 compounds tested, 24 showed promising α-glucosidase inhibition, with some compounds demonstrating better efficacy than the standard drug acarbose, indicating the need for further bioassay studies.
View Article and Find Full Text PDF

A series of benzimidazole-acrylonitrile derivatives were designed with urease inhibition approach. were synthesized and characterized (H Nuclear Magnetic Resonance (NMR), C NMR, Mass Spectroscopy (MS) and IR) and subjected to urease inhibition assay using commercial assay kit. A molecular docking study was also performed using Autodock tool software.

View Article and Find Full Text PDF

With fungal diseases posing a major threat to agricultural production, the application of fungicides to control related diseases is often considered necessary to ensure the world's food supply. The search for new bioactive agents has long been a priority in crop protection due to the continuous development of resistance against currently used types of active compounds. Heterocyclic compounds are an inseparable part of the core structures of numerous lead compounds, these rings constitute pharmacophores of a significant number of fungicides developed over the past decade by agrochemists.

View Article and Find Full Text PDF

α-Glucosidase inhibition is an approved treatment for type 2 diabetes mellitus (T2DM). In an attempt to develop novel anti-α-glucosidase agents, two series of substituted imidazo[1,2-c]quinazolines, namely 6a-c and 11a-o, were synthesized using a simple, straightforward synthetic routes. These compounds were thoroughly characterized by IR, H and C NMR spectroscopy, as well as mass spectrometry and elemental analysis.

View Article and Find Full Text PDF